We’re still waiting for Chairman Sandy Beard to update the market on his enquiries last year he committed to make concerning AN1’s overdue royalties and likely capital lump sum due under the Lyramid P/L Midkine contract with Roqueford.
If Roqueford Therapeutics has sold Lyramid P/L with the Midkine fgf5 licences in February 2025 to another Pharma (see Roqueford ann) what does that mean for AN1’s recent fgf5 licence agreement with boeuf hair car if AN1 is out of the licensing loop?
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $2.481M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 1293665 | 0.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.7¢ | 332362 | 2 |
View Market Depth
| Last trade - 16.30pm 25/07/2025 (20 minute delay) ? |
| AN1 (ASX) Chart |
Day chart unavailable